Key Highlights
- PathPresenter closes $7.5M Series A funding led by AVANT BIO
- Funds to enhance platform features and advance regulatory milestones
- PathPresenter supports over 50 top-tier institutions in digital pathology workflows
- Platform leverages AI algorithms to improve patient outcomes
- Founded by Dr. Rajendra Singh, a pioneer in digital pathology
Source: Newswire
Notable Quotes
- “By establishing a standards-based, open environment that offers labs choice and ensures tight integration, vendors will help overcome one of the leading barriers to user adoption.” — Imogen Fitt, Senior Market Analyst at Signify Research
- “PathPresenter’s vision to unlock digital pathology’s potential through improved connectivity and accessibility aligns with AVANT BIO’s mission.” — Sebastien Latapie, Principal at AVANT BIO
- “Our recent funding round has brought in more outstanding partners who share our vision and their support will be key in expanding PathPresenter’s reach.” — Dr. Rajendra Singh, Founder at PathPresenter
SoHC's Take
PathPresenter’s recent $7.5M Series A funding round underscores the growing demand for vendor-agnostic, interoperable solutions in the digital pathology landscape. With an emphasis on leveraging AI algorithms and integrating multiple vendor tools, PathPresenter is strategically positioned to lead the digital transformation in pathology workflows. By breaking down barriers to user adoption and enabling seamless collaboration across institutions globally, the company is creating a more connected and efficient pathology ecosystem. This investment not only validates PathPresenter’s innovative approach but also highlights the critical role interoperability will play in driving future advancements in digital pathology.
Heading
Key Highlights Shore Capital Partners launches Agentis Longevity to lead the longevity healthcare sector. Jimmy St Louis named CEO, bringing expertise from Regenerative Medicine ...
Key Highlights Nymbl Systems announces strategic partnership with Frontier Growth to accelerate growth and innovation. Frontier Growth brings 25+ years of growth equity expertise to ...
Key Highlights Launch of fingertip blood collection technology using BD’s MiniDraw™ and Babson’s BetterWay for U.S. health systems. Revolutionizes access with fewer ...
Key Highlights Anatomy Financial raises $19M in Series A funding, led by Canapi Ventures. Neil Underwood (Canapi) and Nicole Quinn ...
Key Highlights Wendy Barnes to assume role as GoodRx CEO on January 1, 2025. Brings 30+ years of leadership in pharmacy and healthcare benefit industries. Former CEO of RxBenefits and President of Express ...
Key Highlights Mike Butler, former Providence president, joins Linus Health's board of directors. Butler brings decades of healthcare leadership and ...
